Canada · Delayed Price · Currency is CAD Loblaw Companies Earnings Call Transcripts
Fiscal Year 2025
-
Q4 and full year 2025 saw strong revenue, EPS, and margin growth, driven by new stores, digital expansion, and operational excellence. 2026 guidance calls for high single-digit EPS growth, continued investment in stores and innovation, and robust capital returns to shareholders.
-
EQB will acquire PC Financial from Loblaw for CAD 800 million, creating a leading digital bank with nearly 3.5 million customers and exclusive access to the PC Optimum loyalty program. The deal is expected to close in the second half of 2026, delivering significant revenue, cost, and funding synergies, and has strong support from both companies’ boards and major shareholders.
-
Revenue grew 4.6% to CAD 19.4B, with adjusted EPS up 11.3% and strong gains in both food and drug retail. Online sales rose 18%, and market share increased in discount and conventional channels. Full-year adjusted EPS growth is now expected in the low double digits.
-
Strong revenue and earnings growth driven by new store openings, market share gains in both discount and conventional banners, and robust performance in pharmacy and online channels. AI-driven efficiencies and a 4-for-1 stock split were announced, with continued confidence in the full-year outlook.
-
The joint AGM highlighted strong financial results, increased dividends, and robust shareholder returns for both companies. Key strategic initiatives include major investments in store and clinic expansion, supply chain diversification, and ESG leadership. All director nominees were elected, and all shareholder proposals were rejected by large margins.
-
Q1 2025 saw 4.1% revenue growth, 9.3% adjusted EPS growth, and stable gross margin, driven by strong food and drug retail performance, new store openings, and digital sales momentum. Tariff and inflation risks are being actively managed, with continued investment in value and growth initiatives.
Fiscal Year 2024
-
Delivered strong 2024 results with revenue of CAD 61B and adjusted EPS up 10.3%. Hard discount and T&T banners led growth, while digital and pharmacy initiatives drove engagement. 2025 guidance calls for high single-digit EPS growth, continued store expansion, and robust capital returns.
-
Q3 2024 saw revenue rise 1.5% to CAD 18.5B and adjusted EBITDA up 7.4%, with EPS growth expected to slightly exceed original guidance. Discount banners and pharmacy outperformed, while front-store sales faced pressure from electronics exit. Gross margin and tonnage growth were strong.
-
Revenue grew 1.5% to CAD 13.9B, with adjusted EBITDA up 4.5% and adjusted EPS up 10.8%. A CAD 156.5M charge for a bread price-fixing settlement impacted GAAP net earnings. Hard discount banners and pharmacy clinics drove growth, with Q3 off to a strong start.